Revision: Feb. 16, 2023, 4:07 p.m.
Health and Human Services
February 16, 2023
2023-0579s
05/08
Amendment to SB 240
Amend RSA 141-H:2, IV as inserted by section 1 of the bill by replacing it with the following:
IV. Nothing in this section shall be construed to regulate or apply to genetic testing or genetic analysis used for diagnosis and treatment of a patient by a clinical laboratory that has received a specimen referral from the individual patient's treating physician, genetic counselor, or another clinical laboratory. Nothing in this section shall be construed so as to waive the requirement that the treating physician obtain specific informed consent in accordance with the provisions of this section. This section shall not prohibit the disclosure of genetic testing or genetic analysis to entities participating in processes related to either clinical care of the patient, including, but not limited to, evaluating potential clinical care options, or to clinical research.